NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors.
Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, the Bedford, Mass.-based company said.
“With the recent strategic partnership NinePoint entered into with Merit Medical, along with Eman’s long history with the technology, business acumen, and strong leadership, this was a natural choice for the Board and a great next step for the company. In addition to Eman’s product vision, he has during his tenure at NinePoint established a track record of building and successfully leading diverse and highly technical teams through the development and commercialization of complex medical instruments. As we look towards future growth opportunities and expand into new indications, his experience and vision will be key to our success,” board chair Tom Miller said in a prepared statement.
Namati will manage day-to-day leadership at NinePoint, the company said, while working in collaboration with Merit Medical (NSDQ:MMSI) who manages sales distribution and customer service for NinePoint’s NvisionVLE imager.
“I am honored and incredibly excited to take on this leadership role during such a pivotal point in the company’s history and look forward to working with Merit Medical on our new strategic partnership. I would like to extend my sincere thanks to Chris for his service to NinePoint and mentorship to me over the past four-years. I am fortunate to be surrounded by a truly talented team with exciting and innovative products in the pipeline. Together, we look forward to continuing our important mission towards early detection of cancer,” Namati said in a press release.
Dr. Greenberg has served as non-exec board chair of the foundation since December 2004, and perviously served as CEO of Second Sight from its inception in 1998 through to 2015.
”I have enjoyed interacting with Dr. Greenberg on the Board of Directors and look forward to working more closely with him to further our founder’s vision,” AMF CEO John Petrovich said in a prepared statement.
In his new position at the Alfred Mann Foundation, Dr. Greenberg will focus on developing partnerships and projects, as well as aiding in existing projects, the group said.
”I have spent my career solving unmet medical needs and look forward to continuing that mission at the Alfred Mann Foundation, an organization committed to the same goals” Dr. Greenberg said in a press release.
Bonesupport said last week that Håkan Johansson will take over the CFO role from Björn Westberg, slated to take effect at the end of this year.
Prior to joining BoneSupport, Johansson served as CFO of Tunstall Northern Europe and CFO of BRIO, the Swedish orthobiologic company said.
“Håkan Johansson has very solid CFO experience and will be a valuable addition to Bonesupport’s leadership team given the exciting journey we have ahead of us. I would like to thank Björn for his support and advice whilst I have served as CEO and his work as a lead contributor to Bonesupport’s successful IPO in June 2017. I wish Björn continued success in his future endeavors,” CEO Emil Billbäck said in a prepared statement.
Titan Spine said today it appointed Brian Burke as its new chief operating officer.
“As we continue to focus on growth, we identified a need to bring on additional executive talent to the Titan Spine team. Brian has extensive experience driving effective and dynamic functional leadership, brings a wealth of experience in the medtech industry working with both privately and publicly held companies, and has demonstrated a proven track record of implementing operational efficiency. We welcome Brian and believe he will be instrumental in expanding Titan’s strategic positioning in the marketplace,” CEO Dr. Peter Ullrich said in a press release.
Karti spent 22 years with GE Healthcare operating in numerous leadership roles, most recently acting as CEO and prez of GE Healthcare’s imaging division, iRhythm Tech said.
“We are pleased to welcome Karim to our leadership team and look forward to the contributions he can make in shaping our strategic direction. He brings a wealth of expertise that complements our leadership team and is vital as our business grows. Karim is a seasoned and trusted leader who has consistently delivered strong results in healthcare technology and is uniquely qualified to drive operational excellence and scale within iRhythm. I have tremendous confidence that his leadership will strengthen our team’s ability to achieve ongoing market leadership and our long term strategic goals,” prez & CEO Kevin King said in a press release.
“I am thrilled and honored to join the iRhythm team. iRhythm is revolutionizing the way to diagnose and treat arrhythmia. Its impressive growth and impact on patients and providers is a testimony to the strength of its solutions and potential for the future. I look forward to working with the world class iRhythm leadership team to continue to drive growth and expansion, as well as further establish iRhythm as a premier digital health solutions platform,” Karti said in a prepared release.
- Cutera taps Richey as COO
- Xtant Medical names Brandt as chief commercial officer
- RTI Surgical CCO steps away
- SeaSpine appoints Cirino as spinal systems senior VP
- Endologix taps Fecho as chief quality officer
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.